Arizona to Spend $2.2M in Stimulus Funds on Lab for Biomarker Assay Standardization
November 05, 2010
Arizona to Spend $2.2M in Stimulus Funds on Lab for Biomarker Assay Standardization
Led by the Critical Path Institute and Roche's Ventana Medical Systems, the project aims to fill a gap in the current biomarker pipeline, and will hopefully speed the progression of proposed biomarkers through the FDA's qualification pipeline, said a C-Path official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Japanese Regulators Approve Critical Path's Protein Biomarker Panel for Drug Toxicity Studies
June 25, 2010 / ProteoMonitor - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor - FDA Approves Roche's Companion Dx and Drug for Melanoma
August 17, 2011 / GenomeWeb Daily News - Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
August 12, 2011 / ProteoMonitor